medigraphic.com
ISSN 2218-6719 (Print)

2018, Number 4

<< Back Next >>

Rev Cub de Tec de la Sal 2018; 9 (4)

Influential factors in Cervical Intraepithelial Neoplasia.

Mendoza RNR, Cristóbal MY, Ojeda DA, Bravo SM

Language: Spanish
References: 39
Page: 3-16
PDF size: 229.10 Kb.


ABSTRACT

Introduction: cervical intraepithelial neoplasia is a health problem in Cuba and in the world. The high rate of morbidity and mortality in women due to this cause is a priority for its control in Primary Health Care. Objective: identify factors associated with cervical intraepithelial neoplasia at "Mario Muñoz Monroe" polyclinic from 2015 to 2017. Method: a case-control study was conducted, the universe was 128 patients diagnosed with cervical intraepithelial neoplasia and a sample of 96 was chosen by sampling at chance that constituted the study group; there was another group (control) consisting of an equal number of patients with negative cytologies; the data collection was through a survey of the patients. The distribution of frequencies in each variable was used; the arithmetic, standard deviation, percentage, Student test, the cross-product ratio and the independence test using chi-square with a confidence level of 95% and a value, p <0.05. Results: cervical intraepithelial neoplasia was more frequent between 20 and 29 years; parity between 3 and 4 births, the history of other benign uterus neck conditions, the early onset of sexual intercourse, nonuse of the condom, and virus of the human papiloma infection were significant risk factors. Conclusions: in the appearance of cervical intraepithelial neoplasia multiple risk factors converged, the elimination and control of them is vital in its prevention and treatment.


REFERENCES

  1. Suárez CM, Díaz V, Ramírez R. Conización amplia una opción terapéutica en el carcinoma in situ de cuello uterino. Rev Ciencias Médicas. 2006; 31: 66-9.

  2. Nazzal O, Suárez E, Larraguibel R, Rojas L, Bronda A. Lesiones preinvasoras de cuello uterino: una visión actual. Rev Chil Obstet Ginecol. 2016; 71(5): 341-8.

  3. Restrepo H. Epidemiología y control del cáncer de la mujer en América Latina y el Caribe. Genero, Mujer y Salud en las Américas. Ginebra: OPS/OMS; 2014.

  4. Lacruz Pelea C. Nomenclatura de las lesiones cervicales (de Papanicolaou a Bethesda 2001). Rev Española Patol. 2016; 36(1): 22-9.

  5. Campanón Logaz JE, Rodiles Martínez HC, Salazar Pérez MC. Citodiagnóstico. La Habana: Editorial Ciencias Médicas; 2008.

  6. Rosell Juarte E, Muñoz Dobarganes A, Cerero Muñoz F, Cardoso Hernández J, Estenoz Fernández A. Factores de riesgo del cáncer de cuello uterino. AMC [en línea] 2007 [fecha de acceso 23 Abril 2011]; 11(1). URL disponible en: http://www.amc.sld.cu/amc/2007/v11n1- 2007/2116.htm

  7. Tinelli A, Leo G, Pisanò M, Storelli F, Leo S, Vergara D, et al. HPV viral activity by mRNA-HPV molecular analysis to screen the transforming infections in precancer cervical lesions. Curr Pharm Biotechnol. 2014; 10(8): 767-71.

  8. Consejo Eurogin. Sobre prueba de detección de AND del HPV en el Cribado de Cáncer de Cuello U. Today. 2016; 9: (10).

  9. Ramírez Polo I. La pandemia de HPV. Su repercusión en la salud reproductiva. Granada: 4to Congreso de la Sociedad Andaluza de Contracepción; 2016.

  10. Harper DM. Current prophylactic HPV vaccines and gynecologic premalignancies. Curr Opin Obstet Gynecol. 2014; 21(6): 457-64.

  11. López RM. Incidencia de lesiones cérvico vaginales premalignas en una población de retomados de Guatemala. Rev Guatemala. 2016; 43: 30-8.

  12. Population Referent Bureau. Alliance for cervical Cancer Prevention. La prevención del cáncer cervical a nivel mundial. Washington DC: PATH; 2014.

  13. León Cruz G, Bosques Diego J. Infección por el virus del papiloma humano y factores relacionados con la actividad sexual en la génesis del cáncer de cuello uterino. Rev Cubana Obstet Ginecol. 2008; 31(1): 40-8.

  14. Piñeros M, Cendales R, Murillo R, Wiesner C, Tovar S. Cobertura de la citología de cuello uterino y factores relacionados en Colombia, 2015. Rev Salud Pública (Bogotá). 2016; 9(3): 327- 341.

  15. Alliance for Cervical Cancer Prevention. World Health Organization. International network for cancer treatment research. Planificación y aplicación de los programas de prevención y control del cáncer cérvico-uterino. Manual para gestores. Ginebra; 2014.

  16. Patil V, Wahab SN, Zadpey S, Vasudeo ND. Development and validation of risk scoring system for prediction of cancer cervix. Indian J Public Health. 2016; 50(1): 38-42.

  17. Wright T, Gogron S, Richard R. Treatment of cervical intraepitelial neoplasia using loop electrosurgical excision procedure. Obstet gynecol. 2015; 68: 243-54.

  18. Rombaldi RL, Serafini EP, Villa LL, Vanni AC, Baréa F, Frassini R, et al. Infection with human papillomaviruses of sexual partners of women having cervical intraepitelial neoplasia. Braz J Med Biol Res. 2016; 9(2): 177-87.

  19. Beard K. Reducing the rate of cervical cancer: ethical challenges in public health. J Natl Nurses Assoc. 2014; 21(2): 39-43.

  20. Odongua N, Chae YM, Kim Mr, Yun JE, Jee SH. Associations between smoking, screening, and death caused by cervical cancer in Korean women. Yonsei Med J. 2014; 48(2): 192-200.

  21. Bosch FX, Bernaola Iturbe E. La vacuna frente al virus del papiloma humano y la incorporación de la pediatría a la prevención del cáncer de cuello uterino. An Pediatr. 2008; 65: 411-3.

  22. Montané Céspedes IA. Papiloma virus humano. Asociación a neoplasia intraepitelial cervical en mujeres del municipio Boyeros. Rev Haban Cienc Méd. 2010; 9(4): 553-559.

  23. Isaza-Ruget MA, Perez G, Morales-Reyes OL, Deantonio-Suárez R, Alvarado-Heine C, Trujillo LM. Exactitud del test ADN-HPV para la detección de la enfermedad cervical de alto grado (NIC 2+) en mujeres con anormalidades citológicas (ASC-US y LSIL), afiliadas a la seguridad social en Bogotá (Colombia). Rev Colomb Obstet Ginecol. 2014; 60(3): 213-222.

  24. Siegler E, Bornstein J. Loop Electrosurgical Excision Procedures in Israel. Gynecol Obstet Invest. 2015.

  25. Ward KK, Berenson AB, Breitkopf CR. Passive smoke exposure and abnormal cervical cytology in a predominantly Hispanic population. Am J Obstet Gynecol. 2014; 204(3): 213.

  26. Matthews R, Azuero A, Asmellash S, Brewster E, Partridge EE, Piyathilake CJ. Usefulness of serum mass spectrometry to identify women diagnosed with higher grades of cervical intraepithelial neoplasia may differ by race. Int J Womens Health. 2014; 3: 185-92.

  27. Sierra Torres CH, Acosta Aragon MP, Orejuela Aristizabal L. Papillomavirus and factors associated with high-risk, cervical intraepithelial neoplasia in Cauca, Colombia. Rev Salud Publica (Bogota). 2014; 8 Suppl 1: 47-58.

  28. Littell RD, Kinney W, Fetterman B, Cox JT, Shaber R, Poitras N, et al. Risk of cervical precancer and cancer in women aged 30 years and older with an HPV-negative low-grade squamous intraepithelial lesion screening result. J Low Genit Tract Dis. 2015; 15(1): 54-9.

  29. Li CD, Zhang WY, Wu MH, Zhang SW, Zhou BL, Zhu L, et al. Analysis of high risk factors associated with cervical intraepithelial neoplasia in married women aged 25 - 54 years in Beijing between. Zhonghua Fu Chan Ke Za Zhi. 2014; 45(10): 757-61.

  30. Clements AE, Raker CA, Cooper AS, Boardman LA. Prevalence and patient characteristics associated with CIN 3 in adolescents. Am J Obstet Gynecol. 2014; 204(2): 128.

  31. Torriente Hernández S, Valdés Alvarez O, Villarreal Martinez A, Lugo Sánchez A. Caracterización de un grupo de pacientes con neoplasia intraepitelial cervical diagnosticadas por biopsia con asa diatérmica. Rev Cubana Obstet Ginecol. 2011; 37(1): 42-53.

  32. López Suárez JC, Pila Díaz RI, Fernández Riverón VR, Pico Ortega LR. Comportamiento de algunos factores de riesgo que influyen en la aparición del cáncer cérvico-uterino en el área norte de Morón. Año 2004. Mediciego. 2007; 13(supl 1).

  33. Pearson GA, Ortashi O. Cervical intraepithelial neoplasia grade III diagnosed at ERPC. J Obstet Gynaecol. 2014; 31(4): 358.

  34. Panyanupap A, Thaweekul Y, Poomtavorn Y, Mairaing K, Suwannarurk K, Pattaraarchachai J, et al. Prevalence of high-grade cervical intraepithelial neoplasia (CIN) in the patients with atypical squamous cells of undetermined significance (ASC-US) pap smears: hospital based, dynamic population area. J Med Assoc Thai. 2014; 94(2): 159-63.

  35. Russo E, Kupek E, Zanine RM. Vaginal delivery and low immunity are strongly associated with high-grade cervical intraepithelial neoplasia in a high-risk population. J Low Genit Tract Dis. 2014; 15(3): 195-9.

  36. Obure J, Olola O, Swai B, Mlay P, Masenga G, Walmer D. Prevalence and severity of cervical squamous intraepithelial lesion in a tertiary hospital in northern Tanzania. Tanzan J Health Res. 2015; 11(4): 163-9.

  37. Vázquez Márquez A, González Aguilera JC, De la Cruz Chávez F, Valdés Martínez R. Factores de riesgo del cáncer de cérvix uterino. Rev Cubana Obstet Ginecol. 2008; 34(2).

  38. Malapati R, Chaparala S, Cejtin HE. Factors influencing persistence or recurrence of cervical intraepithelial neoplasia after loop electrosurgical excision procedure. J Low Genit Tract Dis. 2015; 15(3): 177-9.

  39. Cullimore JE, Waddell C. Cervical cytology and glandular neoplasia. BJOG. 2015; 117(9): 1047-50.




2020     |     www.medigraphic.com